Wordt geladen...
Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk
Rivaroxaban is a direct factor Xa inhibitor that is widely available to reduce the risk of stroke or systemic embolism in patients with nonvalvular atrial fibrillation and one or more risk factors for stroke. Rivaroxaban provides practical advantages compared with warfarin and other vitamin K antago...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3956810/ https://ncbi.nlm.nih.gov/pubmed/24648742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S55246 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|